Nasdaq Flags Cypherpunk Technologies for Sub-$1.00 Bid Price
CYPH has more than doubled off its 52-week low of $0.232 on light trading volume (0.3× avg).
Summary
On July 20, 2026, Cypherpunk Technologies received a Nasdaq deficiency notice because its stock closed below $1.00 for 30 consecutive days. The company has until January 19, 2027, to regain compliance and may consider a reverse stock split.
Key Events · Legal and Risk Events · CYPH
-
Nasdaq Deficiency Notice Received
On July 20, 2026, Nasdaq notified Cypherpunk Technologies that its closing bid price had been below the $1.00 minimum for 30 consecutive business days, violating Listing Rule 5550(a)(2).
-
Compliance Deadline Set
The company has 180 days, until January 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. An additional 180-day extension may be available if certain conditions are met.
-
Reverse Stock Split Considered
Management stated it will consider all options to regain compliance, including a reverse stock split, though no assurance of success was given.
-
Recent Financial Distress
The deficiency notice follows a $77.2 million net loss in Q1 2026 and declining cash and digital asset balances, as reported in the May 2026 10-Q.
Analysis · CYPH · Life Sciences
Nasdaq has notified Cypherpunk Technologies that its stock price fell below the $1.00 minimum for 30 consecutive business days, putting the listing at risk. The company now has 180 days to regain compliance, with a possible 180-day extension. This notice arrives just two months after Cypherpunk regained compliance from a prior bid price deficiency, and against a backdrop of a $77.2 million net loss in Q1 2026 and declining cash reserves. While the notice does not immediately delist the stock, it signals ongoing financial distress and raises the specter of a reverse stock split to meet the requirement.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CYPH was trading at $0.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $78.7M. The 52-week trading range was $0.23 to $3.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.